Cesar Arias, M.D., Ph.D., associate professor in the Division of Infectious Diseases at The University of Texas Health Science Center at Houston (UTHealth) Medical School, was bestowed the Oswald Avery Award for Early Achievement from the Infectious Diseases Society of America (IDSA).
The presentation was made on Oct. 3 in San Francisco at an annual meeting of the IDSA, the Society for Healthcare Epidemiology of America, the HIV Medicine Association and the Pediatric Infectious Diseases Society. The meeting is called IDWeek 2013.
The award recognizes outstanding achievement in an area of infectious diseases by a member of the IDSA who is 45 years of age or younger.
Arias' research is focused on stemming the spread of antibiotic-resistant bacteria known as superbugs, which are considered one of the major health threats of the 21st Century. Arias operates research laboratories in the United States and Colombia.
"Dr. Arias received the top award for early achievement by a clinician scientist in infectious diseases in the United States. Dr. Arias' imaginative research focuses on antibiotic resistance that causes countless suffering and death, and costs our country more than $30 billion each year," said Herbert DuPont, M.D., past president of the IDSA and director of the Center for Infectious Diseases at The University of Texas School of Public Health, part of UTHealth.
"Dr. Arias' research is global and the impressive center he established in Colombia adds to his important contributions to the field and furthers international medical knowledge on antibiotic resistance recognizing the worldwide movement of disease-causing microbes," said DuPont, holder of the Mary W. Kelsey Chair in the Medical Sciences at the UTHealth Medical School